News | PACS | March 14, 2018

Fujifilm Showcases Enterprise Imaging Portfolio and AI Initiative at HIMSS 2018

Fujifilm is working to integrate artificial intelligence to improve workflow in its Synapse 5 PACS

Fujifilm Showcases Enterprise Imaging Portfolio and AI Initiative at HIMSS 2018

March 14, 2018 — Fujifilm Medical Systems U.S.A. Inc. recently showcased its enterprise imaging and informatics solutions at the Healthcare Information and Management Systems Society’s (HIMSS) Annual Conference and Exhibition, held March 5-9, 2018 in Las Vegas. In addition to its extensive product portfolio, Fujifilm announced the expansion of its Artificial Intelligence (AI) Research Project into the U.S. market. Fujifilm’s AI development initiative will harness the power of AI to enhance its Synapse Enterprise Imaging and Medical Informatics portfolio. The company also introduced its newest brand REiLI, which will represent Fujifilm’s global Medical Informatics and Imaging AI technology Initiative.

Fujifilm’s Artificial Intelligence Research Project is based in Raleigh, N.C. — the global development headquarters for the Synapse Enterprise Imaging portfolio — in collaboration with Fujifilm Corp.’s development team in Tokyo that will provide a wide range of image recognition technologies. Fujifilm will partner with its strategic customers in the U.S. market to draw upon clinical insights and expertise to bridge AI applications to imaging informatics solutions. In an increasingly complex healthcare environment with massive datasets and rising demand for high-quality care, AI technology will have the potential to change the practice of medicine, according to the company.

Fujifilm Vice President of Medical informatics Bill Lacy said the company has received very positive feedback from healthcare professionals that have already seen live demonstrations of the AI Research Project, specifically regarding the speed and depth of integrated workflow achieved with the Synapse 5 server-side picture archiving and communication system (PACS).

“As we focus initially on radiology, and with a clear focus on supporting and collaborating with radiologists, not replacing them, artificial intelligence technology can help radiologists aggregate PHI faster for more informed decisions, and prioritize their work and time more effectively,” he added.

More information on Fujifilm’s AI Research Project was demonstrated at the company’s HIMSS booth alongside the following products:  

Synapse VNA — At the core of Fujifilm's comprehensive Enterprise Imaging portfolio, the TeraMedica division of Fujifilm’s Synapse VNA (vendor neutral archive) integrates more specialties, more devices and more data than any other VNA, according to the company. Healthcare organizations can achieve cost savings, improve clinical outcomes, optimize workflow efficiencies, securely manage all departmental data and experience imaging interoperability through the combination of Synapse VNA, Synapse Mobility Enterprise Viewer and Virtual Image Exchange.

Synapse 5 PACS — Designed with speed and functionality in mind, Synapse 5 PACS is a next-generation, secure server-side technology that enables instant access of massive datasets, working within the most popular browsers while using less bandwidth throughout the enterprise. Synapse 5 PACS powered with Synapse Communications features an enhanced suite of integrated tools including an integrated point-of-care solution, emergency department findings, results escalation and tracking, radiologist peer review, helping create a tailored workflow and a closed loop of communication between the radiology and all clinical departments.

Synapse RIS — Synapse RIS (radiology information system) helps radiology facilities take command of their operations. Synapse RIS is a full-featured workflow management system that is fully integrated with Synapse 5 PACS. It features an advanced scheduling intelligence engine, a patient portal, business intelligence analytics and productivity-boosting tools that include universal worklist and paperless consent forms. With its flexible architecture and modern interoperability standards, Synapse RIS allows practices to easily integrate with physicians in their community.

Synapse Cardiovascular — Developed with ongoing direction from cardiologists, Synapse Cardiovascular offers capabilities and tools that help streamline, image review and reporting across cardiac catheterization, electrocardiogram (ECG) management, echocardiography, nuclear cardiology, 3-D imaging and vascular ultrasound workflows.

Synapse 3-D — Designed for use across multiple specialties including radiology, cardiology, surgery and more, Synapse 3-D is an enterprise-wide solution for quickly performing advanced visualization workflows and accessing 3-D-rendered images. Full integration with Synapse 5 PACS and Synapse Cardiovascular allows one-click access from any Synapse client.

Synapse Cloud Services — A scalable environment shaped to host and manage the Synapse Enterprise Imaging portfolio. Critical-access hospitals, imaging centers and teleradiology providers can take advantage of Fujifilm’s cloud-based infrastructure and interoperability of software to maximize efficiency and cost savings.

For more information: www.fujimed.com

 

Related Content

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019. Photo by Greg Freiherr

Feature | Radiology Business | July 22, 2019 | By Greg Freiherr
Efforts to reform healthcare are booming, b
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho